Las Vegas Sands Corp. (LVS) fell -0.92% during last trading as the stock lost $-0.49 to finish the day at $52.51 with about 4.67M shares changing hands, compared to its three month average trading volume of 4.83M. The $41.89B market cap company, which fluctuated between $52.13 and $53.1 during the day, currently situated 29.93% above its 52 week low of $41.25 and -16.09% away from its one year high of $63.38. The RSI of 40.38 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.
Las Vegas Sands Corp., together with its subsidiaries, develops, owns, and operates integrated resorts in Asia and the United States. It owns and operates The Venetian Macao Resort Hotel, Sands Cotai Central, the Four Seasons Hotel Macao, Cotai Strip, the Plaza Casino, and the Sands Macao in Macao, the People’s Republic of China; and iconic Marina Bay Sands in Singapore. The company also owns and operates The Venetian Resort Hotel Casino, The Palazzo Resort Hotel Casino, and Five-Diamond luxury resorts on the Las Vegas Strip; Sands Expo and Convention Center in Las Vegas, Nevada; and the Sands Casino Resort Bethlehem in Bethlehem, Pennsylvania. Its integrated resorts include accommodations, gaming, entertainment and retail, convention and exhibition facilities, celebrity chef restaurants, and other amenities. Las Vegas Sands Corp. was founded in 1988 and is based in Las Vegas, Nevada.
Mead Johnson Nutrition Company (MJN) dropped $-0.08 to close the day at a new closing price of $87.6, a -0.09% decrease in value from its previous closing price that moved the stock 26.56% above its 52 week low of $69.25. A total of 4.67M shares exchanged hands during the day compared with its three month average trading volume of 3.28M. The stock, which fluctuated between $87.6 and $87.89 during the day, currently situated -6.17% below its 52 week high. The stock is up by 16.41% in the past one month and up by 23.02% over the past three months. With a one year target estimate of $81.7 and RSI of 74.88, the stock still has upside potential, making it a sell for now.
Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children’s nutrition, and other nutritional products. It offers routine infant formula products as a breast milk substitute for healthy infants for use as the infant’s source of nutrition, as well as a supplement to breastfeeding under the Enfamil Premium, Enfapro Premium, Enfalac A+, and Enfamil A+ names; and solutions products to address common feeding tolerance problems, including spit-up, fussiness, gas, and lactose intolerance under the Enfamil Gentlease, Enfamil A.R., Enfamil ProSobee, and Enfamil LactoFree names. The company also provides specialty formula products, including formulas for addressing special medical needs, such as Nutramigen for cow’s milk protein allergies, as well as Puramino, an amino acid formula for cow’s milk protein allergies or multiple other food allergies; Enfamil Premature to meet the needs of premature and low birth weight infants; EnfaCare, a hypercaloric formula for premature babies at home; and produces medical foods for nutritional management of individuals with rare, inborn errors of metabolism comprising maple syrup urine disease and phenylketonuria. In addition, it offers children’s nutrition products comprising products for meeting children’s nutritional needs at toddlers and older children stage, as well as offer milk modifiers under the Enfagrow, Sustagen, Lactum, ChocoMilk, and Cal-C-Tose names; a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nursing mothers under the Expecta and EnfaMama names; and pediatric vitamin products under the Enfamil Poly-Vi-Sol name, as well as multivitamins and iron supplements for infants. The company sells its products to mothers, health care professionals, and retailers in approximately 50 countries in Asia, North America, Latin America, and Europe. Mead Johnson Nutrition Company was founded in 1905 and is headquartered in Glenview, Illinois.
Cabot Oil & Gas Corporation (COG) had a light trading with around 4.64M shares changing hands compared to its three month average trading volume of 6.68M. The stock traded between $23.03 and $24.04 before closing at the price of $23.12 with -3.22% change on the day. The Houston Texas 77024 based company is currently trading 25.55% above its 52 week low of $18.73 and -13.38% below its 52 week high of $26.74. Both the RSI indicator and target price of 52.49 and $28.34 respectively, lead us to believe that it should be put on hold over the coming weeks.
Cabot Oil & Gas Corporation, an independent oil and gas company, develops, exploits, explores for, produces, and markets natural gas, oil, and natural gas liquids in the United States. The company primarily focuses on the Marcellus Shale in northeast Pennsylvania with approximately 200,000 net acres in the dry gas window of the play; and the Eagle Ford Shale in south Texas with approximately 85,500 net acres in the oil window of the play. It also transports, stores, gathers, and purchases natural gas for resale. The company sells its natural gas to industrial customers, local distribution companies, and gas marketers through gathering systems and pipelines, as well as to intrastate pipelines, natural gas processors, and marketing companies. As of December 31, 2015, it had proved reserves of approximately 8,190 billion cubic feet of natural gas equivalent. The company was founded in 1989 and is headquartered in Houston, Texas.